Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
14. August 2024 16:05 ET
|
Cyclacel
Cyclacel provides Q2 2024 financial results and business update on fadraciclib precision medicine strategy
Federman & Sherwood Investigates CDK Global for Data Breach
23. Juni 2024 11:51 ET
|
Federman & Sherwood
Federman & Sherwood Investigates CDK Global for Data Breach
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
22. Dezember 2023 09:15 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Uber for Business Announces Integration with CDK Global, Driving Better Customer Experiences at Car Dealerships
24. Januar 2023 12:00 ET
|
Uber for Business
SAN FRANCISCO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Uber for Business, Uber’s global enterprise platform for managing business rides, meals, and deliveries, today announced an integration with CDK...
Cyclacel to Present at the Oppenheimer 31st Annual Healthcare Conference
15. März 2021 07:16 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 15, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...
Cyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference
10. Februar 2021 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results
12. August 2020 16:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results
12. Mai 2020 16:05 ET
|
Cyclacel
- Conference Call Scheduled May 12, 2020 at 4:30 p.m. ET - - Following Recent Financing Cash Runway to End of 2022 - BERKELEY HEIGHTS, N.J., May 12, 2020 (GLOBE NEWSWIRE) -- Cyclacel...
Cyclacel Announces Closing of $20 Million Public Offering
24. April 2020 16:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., April 24, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing...
CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
21. April 2020 08:27 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., April 21, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing...